Stoke Therapeutics
STOK
STOK
105 hedge funds and large institutions have $533M invested in Stoke Therapeutics in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
2.67% less ownership
Funds ownership: 109.91% → 107.24% (-2.7%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
94% less call options, than puts
Call options by funds: $308K | Put options by funds: $5.57M
Holders
105
Holding in Top 10
2
Calls
$308K
Puts
$5.57M
Top Buyers
| 1 | +$11.4M | |
| 2 | +$4.74M | |
| 3 | +$2.79M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.02M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.88M |
Top Sellers
| 1 | -$14.9M | |
| 2 | -$9.51M | |
| 3 | -$3.77M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.29M |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$2.71M |